Functional characterization of TcaA: Minimal requirement for teicoplanin susceptibility and role in Caenorhabditis elesans virulence

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 11, 2007, Pages 3836-3843

  McCallum, Nadine ^a   Brassinga, Ann Karen C ^b   Sifri, Costi D ^b   Berger Bächi, Brigitte ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; MEMBRANE PROTEIN; PROTEIN TCAA; PROTEIN VRASR; REGULATOR PROTEIN; TEICOPLANIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CAENORHABDITIS ELEGANS; CARBOXY TERMINAL SEQUENCE; CELL WALL; DELETION MUTANT; GENE EXPRESSION REGULATION; GENE FUSION; GENE OVEREXPRESSION; NONHUMAN; PHOA GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN INDUCTION; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION REGULATION; ZINC FINGER MOTIF;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CAENORHABDITIS ELEGANS; DRUG RESISTANCE, BACTERIAL; GENETIC COMPLEMENTATION TEST; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS (GENETICS); STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TEICOPLANIN; VIRULENCE;

EID: 35848941461     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00722-07     Document Type: Article

References (42)

1. Appelbaum, P. C. 2006. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 12(Suppl. 1):16-23.
2. Bae, T., A. K. Banger, A. Wallace, E. M. Glass, F. Åslund, O. Schneewind, and D. M. Missiakas. 2004. Staphylococcus aureus virulence genes identified by bursa aurealis mutagensis and nematode killing. Proc. Natl. Acad. Sci. USA 101:12312-12317.
3. Bae, T., and O. Schneewind. 2006. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55:58-63.
4. Begun, J., J. M. Gaiani, H. Rohde, D. Mack, S. B. Calderwood, F. M. Ausubel, and C. D. Sifri. 2007. Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses. PLoS Pathog. 3:e57.
5. Begun, J., C. D. Sifri, S. Goldman, S. B. Calderwood, and F. M. Ausubel. 2005. Staphylococcus aureus virulence factors identified by using a highthroughput Caenorhabditis elegans-kilUng model. Infect. Immun. 73:872-877.
6. Bischoff, M., M. Roos, J. Putnik, A. Wada, P. Glanzmann, P. Giachino, P. Vaudaux, and B. Berger-Bachi. 2001. Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance. FEMS Microbiol. Lett. 194:77-82.
7. Brandenberger, M., M. Tschierske, P. Giachino, A. Wada, and B. Berger-Bachi. 2000. Inactivation of a novel three-cistronic Operon tcaR-tcaA-tcaB increases teicoplanin resistance in Staphylococcus aureus. Biochim. Biophys. Acta Gen. Subjects 1523:135-139.
8. Brenner, S. 1974. The genetics of Caenorhabditis elegans. Genetics 77:71-94.
9. Courvalin, P. 2006. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 42:S25-S34.
10. Cserzo, M., E. Wallin, I. Simon, G. von Heijne, and A. Elofsson. 1997. Prediction of transmembrane alpha-helices in procariotic membrane proteins: the dense alignment surface method. Protein Eng. 10:673-676.
11. Cui, L., J. Q. Lian, H. M. Neoh, E. Reyes, and K. Hiramatsu. 2005. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 49:3404-3413.
12. Drew, D., D. Sjostrand, J. Nilsson, T. Urbig, C. N. Chin, J. W. de Gier, and G. von Heijne. 2002. Rapid topology mapping of Escherichia coli innermembrane proteins by prediction and PhoA/GFP fusion analysis. Proc. Natl. Acad. Sci. USA 99:2690-2695.
13. Gill, S. R., D. E. Fouts, G. L. Archer, E. F. Mongodin, R. T. Deboy, J. Ravel, I. T. Paulsen, J. F. Kolonay, L. Brinkac, M. Beanan, R. J. Dodson, S. C. Daugherty, R. Madupu, S. V. Angiuoli, A. S. Durkin, D. H. Haft, J. Vamathevan, H. Khouri, T. Utterback, C. Lee, G. Dimitrov, L. Jiang, H. Qin, J. Weidman, K. Tran, K. Kang, I. R. Hance, K. E. Nelson, and C. M. Fraser. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187:2426-2438.
14. Glanzmann, P., J. Gustafson, H. Komatsuzawa, K. Ohta, and B. Berger-Bachi. 1999. glmM Operon and methicillin-resistant glmM suppressor mutants in Staphylococcus aureus. Antimicrob. Agents Chemother. 43:240-245.
15. Goda, S. K., and N. P. Minton. 1995. A simple procedure for gel electrophoresis and Northern blotting of RNA. Nucleic Acids Res. 16:3357-3358.
16. Howden, B. P. 2005. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA). Intern. Med. J. 35(Suppl. 2):S136-S140.
17. Juretic, D., L. Zoranic, and D. Zucic. 2002. Basic charge clusters and predictions of membrane protein topology. J. Chem. Infect. Comput. Sci. 42:620-632.
18. Kall, L., A. Krogh, and E. L. L. Sonnhammer. 2004. A combined transmembrane topology and signal peptide prediction method. J. Mol. Biol. 338:1027-1036.
19. Komatsuzawa, H., T. Fujiwara, H. Nishi, S. Yamada, M. Ohara, N. McCallum, B. Berger-Bachi, and M. Sugai. 2004. The gate controlling cell wall synthesis in Staphylococcus aureus. Mol. Microbiol. 53:1221-1231.
20. Kreiswirth, B. N., S. Lofdahl, M. J. Betley, M. O'Reilly, P. M. Schlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709-712.
21. Kuroda, M., H. Kuroda, T. Oshima, F. Takeuchi, H. Mori, and K. Hiramatsu. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807-821.
22. Kuroda, M., K. Kuwahara-Arai, and K. Hiramatsu. 2000. Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. Biochem. Biophys. Res. Commun. 269:485-490.
23. Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, J. Lian, T. Ito, M. Kanamori, H. Matsumaru, A. Maruyama, H. Murakami, A. Hosoyama, Y. Mizutani-Ui, N. K. Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S. Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yamashita, K. Oshima, K. Furuya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and K. Hiramatsu. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
24. Lee, E., and C. Manoil. 1994. Mutations eliminating the protein export function of a membrane-spanning sequence. J. Biol. Chem. 269:28822-28828.
25. Maki, H., N. McCallum, M. Bischoff, A. Wada, and B. Berger-Bachi. 2004. TcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 48:1953-1959.
26. McAleese, F., S. W. Wu, K. Sieradzki, P. Dunman, E. Murphy, S. Projan, and A. Tomasz. 2006. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S. aureus-type resistance to vancomycin. J. Bacteriol. 188:1120-1133.
27. McCallum, N., M. Bischoff, H. Maki, A. Wada, and B. Berger-Bachi. 2004. TcaR, a putative MarR-like regulator of sarS expression. J. Bacteriol. 186:2966-2972.
28. McCallum, N., H. Karauzum, R. Getzmann, M. Bischoff, P. Majcherczyk, B. Berger-Bachi, and R. Landmann. 2006. In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance. Antimicrob. Agents Chemother. 50:2352-2360.
29. McCallum, N., G. Spehar, M. Bischoff, and B. Berger-Bachi. 2006. Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureus. Biochim. Biophys. Acta Gen. Subjects 1760:1475-1481.
30. Michaelis, S., H. Inouye, D. Oliver, and J. Beckwith. 1983. Mutations that alter the signal sequence of alkaline phosphatase in Escherichia coli. J. Bacteriol. 154:366-374.
31. Mongodtn, E., J. Finan, M. W. Climo, A. Rosato, S. Gill, and G. L. Archer. 2003. Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin. J. Bacteriol. 185:4638-4643.
32. Nishi, H., H. Komatsuzawa, T. Fujiwara, N. McCallum, and M. Sugai. 2004. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob. Agents Chemother. 48:4800-4807.
33. Rossi, J., M. Bischoff, A. Wada, and B. Berger-Bachi. 2003. MsrR, a putative cell envelope-associated element involved in Staphylococcus aureus sarA attenuation. Antimicrob. Agents Chemother. 47:2558-2564.
34. Ruzin, A., A. Severin, S. L. Moghazeh, J. Etienne, P. A. Bradford, S. J. Projan, and D. M. Shlaes. 2003. Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus. Biochim. Biophys. Acta Gen. Subjects 1621:117-121.
35. Sakoulas, G., R. C. J. Moellering, and G. M. Eliopoulos. 2006. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin. Infect. Dis. 42(Suppl. 1):S40-S50.
36. Sieradzki, K., M. G. Pinho, and A. Tomasz. 1999. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J. Biol. Chem. 274:18942-18946.
37. Sieradzki, K., and A. Tomasz. 1998. Suppression of glycopeptide resistance in a highly teicoplanin-resistant mutant of Staphylococcus aureus by transposon inactivation of genes involved in cell wall synthesis. Microb. Drug Resist. 4:159-168.
38. Sifri, C. D., A. Baresch-Bernal, S. B. Calderwood, and C. von Eiff. 2006. Virulence of Staphylococcus aureus small colony variants in the Caenorhabditis elegans infection model. Infect. Immun. 74:1091-1096.
39. Sifri, C. D., J. Begun, F. M. Ausubel, and S. B. Calderwood. 2003. Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect. Immun. 71:2208-2217.
40. Tusnády, G. E., and I. Simon. 2001. The HMMTOP transmembrane topology prediction server. Bioinformatics 17:849-850.
41. Utaida, S., P. M. Dunman, D. Macapagal, E. Murphy, S. J. Projan, V., K. Singh, R. K. Jayaswal, and B. J. Wilkinson. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149:2719-2732.
42. Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Diekema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2439-2444.